Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
ACS Biomaterials Science & Engineering|March 13, 2026
A Comprehensive Review of Metal-Based Nanozymes for ROS Scavenging and Therapeutic Applications in OsteoarthritisHaofan Liu, Tongtong Li, Siqi Zhao, et al.
Circulation. Genomic and Precision Medicine|July 18, 2025
VEGFA Stop-Gained Variant Deteriorates Cardiac Remodeling in Myocardial InfarctionZhongxiang Chen, Diqi Zhu, Kaa Seng Lai, et al.
British Journal of Clinical Pharmacology|November 19, 2016
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphomaSuresh K Agarwal, Ahmed Hamed Salem, Alexey V Danilov, et al.
The Science of the Total Environment|July 21, 2023
Biochar may alter plant communities when remediating the cadmium-contaminated soil in the saline-alkaline wetlandZirui Meng, Xunqiang Mo, Weiqing Meng, et al.
Proteome Science|October 25, 2024
Genome-wide computational analysis of the dirigent gene family in Solanum lycopersicumMuhammad Abu Bakar Saddique, Ge Guan, Beibei Hu, et al.
Frontiers in Pharmacology|May 27, 2024
Genetic diversity, clinical uses, and phytochemical and pharmacological properties of safflower (Carthamus tinctorius L.): an important medicinal plantHao Cheng, Chenglong Yang, Pengliang Ge, et al.
The Journal of Infectious Diseases|September 11, 2019
Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered With Human Immunodeficiency Virus AntiretroviralsMatthew P Kosloski, Rajneet Oberoi, Stanley Wang, et al.
Journal of Hepatology|February 4, 2015
Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvirRajeev M Menon, Prajakta S Badri, Tianli Wang, et al.
Aging and Disease|June 6, 2025
Neutrophil Extracellular Traps Promote AIM2-Dependent Microglial Pyroptosis Following StrokeHanze Chen, Linhui Ni, Jinhua Zhang, et al.
Investigational New Drugs|March 20, 2020
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFRJames M Cleary, Emiliano Calvo, Victor Moreno, et al.
Pageof 11